CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

Go back to CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
(NASDAQ: CRSP) Delayed: 55.79 -0.7 (1.24%)
Previous Close $56.49    52 Week High $18.88 
Open $56.06    52 Week Low $13.75 
Day High $57.21    P/E N/A 
Day Low $55.35    EPS $0.00 
Volume 904,293